Key Financial Inc’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-66
| Closed | -$864 | – | 1397 |
|
|
2025
Q4 | $864 | Hold |
66
| – | – | ﹤0.01% | 1272 |
|
|
2025
Q3 | $498 | Hold |
66
| – | – | ﹤0.01% | 1339 |
|
|
2025
Q2 | $354 | Hold |
66
| – | – | ﹤0.01% | 1357 |
|
|
2025
Q1 | $352 | Hold |
66
| – | – | ﹤0.01% | 1314 |
|
|
2024
Q4 | $590 | Hold |
66
| – | – | ﹤0.01% | 1273 |
|
|
2024
Q3 | $727 | Hold |
66
| – | – | ﹤0.01% | 1226 |
|
|
2024
Q2 | $601 | Hold |
66
| – | – | ﹤0.01% | 1230 |
|
|
2024
Q1 | $929 | Hold |
66
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q4 | $507 | Hold |
66
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q3 | $492 | Hold |
66
| – | – | ﹤0.01% | 1248 |
|
|
2023
Q2 | $550 | Hold |
66
| – | – | ﹤0.01% | 1289 |
|
|
2023
Q1 | $878 | Hold |
66
| – | – | ﹤0.01% | 1050 |
|
|
2022
Q4 | $597 | Hold |
66
| – | – | ﹤0.01% | 1081 |
|
|
2022
Q3 | $1K | Hold |
66
| – | – | ﹤0.01% | 1000 |
|
|
2022
Q2 | $0 | Hold |
66
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q1 | $0 | Hold |
66
| – | – | ﹤0.01% | 1062 |
|
|
2021
Q4 | $0 | Hold |
66
| – | – | ﹤0.01% | 952 |
|
|
2021
Q3 | $1K | Sell |
66
-1
| -1% | -$10 | ﹤0.01% | 842 |
|
|
2021
Q2 | $1K | Hold |
67
| – | – | ﹤0.01% | 800 |
|
|
2021
Q1 | $1K | Hold |
67
| – | – | ﹤0.01% | 708 |
|
|
2020
Q4 | $1K | Buy |
+67
| New | +$1.19K | ﹤0.01% | 661 |
|
|
2020
Q2 | – | Sell |
-67
| Closed | -$2K | – | 130 |
|
|
2020
Q1 | $2K | Buy |
+67
| New | +$2.08K | ﹤0.01% | 593 |
|
Key Financial Inc's ATXS Position: Q1 2026 in Review
Key Financial Inc sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 66 shares — an estimated $864 sold.
Key Financial Inc first reported a position in ATXS in Q1 2020 and held it in 22 quarters. The position peaked at $2K in Q1 2020. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Key Financial Inc reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Key Financial Inc sold 66 Astria Therapeutics shares in Q1 2026, an estimated $864.
- Key Financial Inc first reported a position in Astria Therapeutics in Q1 2020 and held it in 22 quarters.
- Key Financial Inc's Astria Therapeutics position peaked at $2K in Q1 2020.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.